Dynamics of tumour angiogenesis: effect of razoxane-induced growth rate slowdown.
Hellmann
K
K
Windleshaw House, Withyham, East Sussex, UK.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000473:pathology; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D011929:Razoxane / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011929:Razoxane